Medical research

FDA approves immunotherapy for dMMR endometrial cancer

The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer that has progressed after treatment ...

Medications

New method facilitates development of antibody-based drugs

In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now, researchers at Lund University in Sweden have developed a new, efficient method based on the 'genetic scissors' ...

page 9 from 40